Johnson & Johnson
The S&P 500 is trading at historically overvalued levels after the Trump rally of the last five months. These 10 stocks are likely to thrive during the next recession.
The New Brunswick, N.J.-based company noted that its pharma sales dipped due to weakness in the U.S. compared to other markets.
It is a very muddled market, and that demands that we stay patient and wait for greater clarity to develop.